Vitamin D supplement labels may be inaccurate (Reuters, 13 February 2013)

Merck shares fall on worries about osteoporosis drug (Reuters, 1 February 2013)

Drug shown to reverse radioiodine resistance in some advanced thyroid cancers (EurekAlert, 14 February 2013)

14 Feb 2013

New research published in the New England Journal of Medicine shows the drug selumetinib may allow thyroid cancer patients who have become resistant to radioiodine therapy to overcome this resistance.

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read